The role of multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy in active surveillance for low-risk prostate cancer: A systematic review

scientific article published on 17 July 2020

The role of multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy in active surveillance for low-risk prostate cancer: A systematic review is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.AMSU.2020.07.015
P932PMC publication ID7398967
P698PubMed publication ID32774849

P2093author name stringAbdulaziz Mohammed Alqahtani
Abdulrahim Mohammed Alamri
Ali Salem Autwdi
Mohammed Mesadef Zogan
Muath Mohammed Almurayyi
Muhammad Ahmad Al-Ghamdi
Nazal Ahmed Almsaoud
Omar Safar Alshahrani
Saeed Ahmed Al-Ghamdi
Sultan Zaher Alshehri
P2860cites workLong-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate CancerQ57696209
Dynamic Contrast-enhanced–magnetic Resonance Imaging Evaluation of Intraprostatic Prostate Cancer: Correlation with Radical Prostatectomy SpecimensQ63966229
Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findingsQ63966237
Dynamic Contrast Enhanced, Pelvic Phased Array Magnetic Resonance Imaging of Localized Prostate Cancer for Predicting Tumor Volume: Correlation With Radical Prostatectomy FindingsQ63966248
Epidemiology of Prostate CancerQ64100343
Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostateQ71927028
Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice studyQ78645486
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statementQ81740105
Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imagingQ82278708
Prostate cancer upgrading with serial prostate MRI scans and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?Q90787531
Multiparametric MRI and radiomics in prostate cancer: a reviewQ91570030
New prostate MRI techniques and sequencesQ91571652
Outcomes of Serial Multiparametric Magnetic Resonance Imaging and Subsequent Biopsy in Men with Low-risk Prostate Cancer Managed with Active SurveillanceQ92417077
Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillanceQ92735758
Recent Global Patterns in Prostate Cancer Incidence and Mortality RatesQ93168738
New Trends in Anterior Cruciate Ligament Reconstruction: A Systematic Review of National Surveys of the Last 5 YearsQ95726331
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationQ21092360
ESUR prostate MR guidelines 2012Q24620926
Prostate MRI based on PI-RADS version 2: how we review and reportQ26749289
Systematic review of complications of prostate biopsyQ26822966
The role of magnetic resonance imaging in the diagnosis and management of prostate cancerQ26849794
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate CancerQ28005473
Active surveillance for prostate cancer: current evidence and contemporary state of practiceQ28066534
Delineation of prognostic biomarkers in prostate cancerQ29617971
Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detect Prostate Cancer in Patients with Prior Negative Transrectal Ultrasound BiopsiesQ30047599
Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.Q30664726
Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group.Q30698121
Active Surveillance for Prostate Cancer: Patient Selection and ManagementQ34111584
Prostate cancer: local staging at 3-T endorectal MR imaging--early experienceQ36320125
Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section HistopathologyQ36983445
Role of MRI in minimally invasive focal ablative therapy for prostate cancer.Q37893860
Detection and localization of prostate cancer with the targeted biopsy strategy based on ADC map: a prospective large-scale cohort studyQ37975995
Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic reviewQ38022388
Risk genes in head and neck cancer: a systematic review and meta-analysis of last 5 years.Q38173952
Automated real-time needle-guide tracking for fast 3-T MR-guided transrectal prostate biopsy: a feasibility study.Q38233902
Role of serial multiparametric magnetic resonance imaging in prostate cancer active surveillance.Q38392814
The incidence of pressure ulcers in surgical patients of the last 5 years: a systematic reviewQ38421420
Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancerQ38924660
Manual search approaches used by systematic reviewers in dermatologyQ39002269
Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancerQ39354036
A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategyQ39525018
Role of Multi-Parametric Magnetic Resonance Image and PIRADS Score in Patients with Prostate Cancer Eligible for Active Surveillance According PRIAS Criteria.Q39863407
Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective studyQ39991700
A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active TreatmentQ40383850
Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancerQ46258204
Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the Partin tablesQ46820013
Evaluation of Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy in Patients with Low-Risk Prostate Cancer Under Active Surveillance Undergoing Surveillance BiopsyQ48517004
Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-upQ50054869
Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease.Q51733070
Outcomes of combination MRI-targeted and transperineal template biopsy in restaging low-risk prostate cancer for active surveillance.Q55519803
Global Trends and Prostate Cancer: A Review of Incidence, Detection, and Mortality as Influenced by Race, Ethnicity, and Geographic LocationQ57106013
P304page(s)171-178
P577publication date2020-07-17
P1433published inAnnals of medicine and surgery (2012)Q27726003
P1476titleThe role of multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy in active surveillance for low-risk prostate cancer: A systematic review
P478volume57

Search more.